To the Point
Shoddy Practices at Big Drug Makers
So-called "compounding pharmacies" regulated by the states have been taking heat since the recent outbreak of meningitis. Today's New York Times reports that one-third of the drug manufacturing industry overseen by the Food and Drug Administration is off line because of "quality issues."
By Warren Olney • • 1 min readSo-called "compounding pharmacies" regulated by the states have been taking heat since the recent outbreak of meningitis. Today's New York Times reports that one-third of the drug manufacturing industry overseen by the Food and Drug Administration is off line because of "quality issues." Katie Thomas covers the business of healthcare for the New York Times.
The full episode
1 of 3
The Pentagon, 'Sequester' and National Security- 0:00Shoddy Practices at Big Drug Makers You’re reading this
- 7:35The Pentagon, 'Sequester' and National Security
- 43:09After 80 Years of Print, Newsweek Going All-Digital
The full episode
1 of 3The Pentagon, 'Sequester' and National Security- 0:00Shoddy Practices at Big Drug Makers You’re reading this
- 7:35The Pentagon, 'Sequester' and National Security
- 43:09After 80 Years of Print, Newsweek Going All-Digital